Cardiology Clinical Trials
Delivering quality care through clinical trials
Baylor College - NCT05650658 - (Left vs. Left)
Study Phase: Observational - Device
Condition(s): Heart Failure with reduced ejection fraction
Treatment of Heart Failure Cardiac Resynchronization Therapy Using His/Left Bundle Branch Pacing vs Biventricular Pacing with a Left Ventricular Epicardial Lead in Patients with Heart Failure (HF) with left ventricular ejection fraction (LVEF) ≤ 50% and with either a Wide QRS complex (> 130 ms) or with/anticipated > 40% Pacing Randomized Clinical Trial (RCT). (Left vs Left RCT)
ClinicalTrials.gov NCT ID: NCT05650658
You can view the full clinical description on ClinicalTrials.gov.
View Full Description
COMPAREPACE PILOT
Efficacy and Safety of Leadless Pacemakers vs. Left Bundle Area Pacing - A Preliminary Exploration
ClinicalTrials.gov NCT ID: NCT06690333
You can view the full clinical description on ClinicalTrials.gov.
View Full Description
Impulse Dynamics - RG_PRO_345 - (INTEGRA-D)
Study Phase: Effectiveness - Device
Condition(s): Heart Failure and reduced ejection fraction
Assessment of the Safety and Efficacy of a Combined Cardiac Contractility Modulation and Implantable Cardioverter Defibrillator Device for Subjects with Heart Failure and Reduced Ejection Fraction
ClinicalTrials.gov NCT ID: NCT05855135
You can view the full clinical description on ClinicalTrials.gov.
View Full Description
Janssen - 70033093ACS3003 - (LIBREXIA-ACS)
Study Phase: Phase III - Drug
Condition(s): Recent acute coronary syndrome
A Phase 3, Randomized, Double-blind, Placebo-controlled, Event-driven Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, After a Recent Acute Coronary Syndrome
ClinicalTrials.gov NCT ID: NCT05754957
You can view the full clinical description on ClinicalTrials.gov.
View Full Description
LifeLens - LL-QUAL-CARDIAC-01
Study Phase: Device
Condition(s): Cardiac Rehab
LifeLens Wireless Physiological Monitor Data Collection in Cardiac Population
Study Purpose
This is data collection study, designed to utilize the LifeLens Wireless Physiological monitor in environments where cardiac care is provided, to collect physiological, contextual and user feedback data from the LifeLens device and standard-of-care devices in support of device development/refinement, validation/regulatory submission(s) and marketing.
Eligibility Criteria
Inclusion criteria:
- Subject is indicated/scheduled for cardiac assessment
- Subject is 18 years old or older
- Subject can consent for themselves
Exclusion criteria:
- Subject has an implantable cardioverter-defibrillator, pacemaker, or plans to have an MRI during the duration of the study
- Subject is unable to consent for themselves and requires consent to be provided by a legally authorized representative
- Subject is younger than 18 years old
- Subject has skin condition(s) on the chest, in the approximate site of anticipated Patch placement
Medtronic - PSR
Study Phase: Observational - Registry
Condition(s): Cardiac rhythm and heart failure
Cardiac Rhythm and Heart Failure: Product Surveillance Registry (PSR) Platform Base
ClinicalTrials.gov NCT ID: NCT01524276
You can view the full clinical description on ClinicalTrials.gov.
View Full Description
To inquire if you're eligible for a clinical trial, contact: (484) 658-5080, or click here to complete a clinical trial inquiry form.
